Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.543
-0.047 (-1.02%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Purple Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cost of Revenue | 0.06 | 0.06 | 0.2 | 0.12 | 0.06 | Upgrade
|
| Gross Profit | -0.06 | -0.06 | -0.2 | -0.12 | -0.06 | Upgrade
|
| Selling, General & Admin | 3.19 | 3.12 | 5.04 | 6.16 | 6.04 | Upgrade
|
| Research & Development | 3.73 | 7.62 | 17.03 | 16.32 | 11.83 | Upgrade
|
| Operating Expenses | 6.92 | 10.74 | 22.08 | 22.48 | 17.87 | Upgrade
|
| Operating Income | -6.98 | -10.8 | -22.27 | -22.6 | -17.92 | Upgrade
|
| Interest & Investment Income | 0.23 | 0.26 | 0.47 | 0.53 | 0.32 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | -0.01 | -0.01 | 0.06 | -0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.73 | 3.48 | 1.83 | 0.25 | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | -6.01 | -7.08 | -19.98 | -21.76 | -17.81 | Upgrade
|
| Asset Writedown | -20.48 | -0.2 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | -0.01 | Upgrade
|
| Pretax Income | -26.49 | -7.28 | -19.98 | -21.76 | -17.83 | Upgrade
|
| Earnings From Continuing Operations | -26.49 | -7.28 | -19.98 | -21.76 | -17.83 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -0.64 | Upgrade
|
| Net Income to Company | -26.49 | -7.28 | -19.98 | -21.76 | -18.47 | Upgrade
|
| Minority Interest in Earnings | 0.11 | 0.04 | 0.1 | 0.09 | 0.08 | Upgrade
|
| Net Income | -26.39 | -7.24 | -19.88 | -21.67 | -18.38 | Upgrade
|
| Net Income to Common | -26.39 | -7.24 | -19.88 | -21.67 | -18.38 | Upgrade
|
| Shares Outstanding (Basic) | 960 | 328 | 221 | 181 | 176 | Upgrade
|
| Shares Outstanding (Diluted) | 960 | 328 | 221 | 181 | 176 | Upgrade
|
| Shares Change (YoY) | 192.79% | 48.15% | 22.41% | 2.92% | 52.76% | Upgrade
|
| EPS (Basic) | -0.03 | -0.02 | -0.09 | -0.12 | -0.10 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.02 | -0.09 | -0.12 | -0.10 | Upgrade
|
| Free Cash Flow | -5.66 | -14.37 | -19.93 | -16.76 | -15.37 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.09 | -0.09 | -0.09 | Upgrade
|
| EBITDA | -6.97 | -10.77 | -22.07 | -22.4 | -17.69 | Upgrade
|
| D&A For EBITDA | 0 | 0.03 | 0.2 | 0.2 | 0.23 | Upgrade
|
| EBIT | -6.98 | -10.8 | -22.27 | -22.6 | -17.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.